Companies / SGRY Surgery Partners, Inc. (SGRY)
Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.
Ticker SGRY Exchange Nasdaq Sector Healthcare Industry Medical Care Facilities Market cap $3.04B 52-week range $11.41 - $23.37 Valuation Share price $23.20 (close of Nov 6, 2026) P/E (TTM) -33.62x Price to book 0.98x Price to free cash flow 16.19x Enterprise value $6.88B Book value per share $23.70 Price performance Period Change 1 day +0.13% 5 days -0.04% 1 month +73.01% 3 months +55.50% 6 months +59.01% Year to date +50.16% 1 year +7.36% 3 years -6.49% 5 years -53.69% 10 years +48.24% All time +22.11%
Short interest As of Oct 15, 2026 Short % of float 21.69% Shares short 14.33M Days to cover 10.34 Change since prior report -0.13% Source FINRA consolidated short interest Profitability and growth Return on equity -2.49% Return on invested capital 5.19% Return on assets -0.96% Return on capital employed 5.19% Gross margin 15.34% Net margin -2.35% EBITDA margin 17.09% Revenue growth 6.24% Free cash flow growth -6.72% Cash flow and balance sheet Free cash flow yield (TTM) 6.18% Current ratio 1.95x Net debt to EBITDA 6.85x Latest reported year Period end Dec 31, 2025 Fiscal year 2025 Revenue $3.31B Cost of revenue $2.80B Gross profit $507.70M EBITDA $565.50M Net income -$77.90M Earnings per share $-0.61 Interest expense $272.60M Shares outstanding 127.21M Income statement by year Period end Revenue Gross profit Net income EPS 2025-12-31 $3.31B $507.70M -$77.90M -$0.61 2024-12-31 $3.11B $487.50M -$168.10M -$1.33 2023-12-31 $2.74B $448.90M -$11.90M -$0.09 2022-12-31 $2.54B $447.40M -$54.60M -$0.59 2021-12-31 $2.23B $406.20M -$70.90M -$1.12 2020-12-31 $1.86B $280.10M -$116.10M -$3.19 2019-12-31 $1.83B $324.50M -$74.80M -$2.29 2018-12-31 $1.77B $171.40M -$205.70M -$4.96 2016-12-31 $1.15B $256.73M $9.45M $0.20 2015-12-31 $959.89M $200.75M $1.43M $0.04
Margins and returns by year Period end Gross margin Net margin Return on equity Return on capital 2025-12-31 15.34% -2.35% -2.49% 5.19% 2024-12-31 15.65% -5.40% -5.26% 3.10% 2023-12-31 16.36% -0.43% -0.39% 5.38% 2022-12-31 17.62% -2.15% -1.86% 5.48% 2021-12-31 18.26% -3.19% -3.60% 5.46% 2020-12-31 15.06% -6.24% -13.16% 4.40% 2019-12-31 17.72% -4.08% -7.61% 5.72% 2018-12-31 9.68% -11.61% -18.72% 1.48% 2016-12-31 22.41% 0.83% 2.91% 10.37% 2015-12-31 20.91% 0.15% 0.48% 8.98%
Cash and debt by year Period end Cash Debt 2025-12-31 $239.90M $3.74B 2024-12-31 $269.50M $3.40B 2023-12-31 $195.90M $2.80B 2022-12-31 $282.90M $2.63B 2021-12-31 $389.90M $2.96B 2020-12-31 $317.90M $2.88B 2019-12-31 $92.70M $2.60B 2018-12-31 $184.30M $2.33B 2016-12-31 $69.70M $1.47B 2015-12-31 $57.93M $1.29B
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-12-31 $195.60M $14.80M 2024-12-31 $209.70M $33.30M 2023-12-31 $205.00M $17.70M 2022-12-31 $78.20M $18.40M 2021-12-31 $29.50M $17.40M 2020-12-31 $204.00M $13.20M 2019-12-31 $55.90M $10.20M 2018-12-31 $104.80M $9.30M 2016-12-31 $86.13M $2.02M 2015-12-31 $51.04M $7.50M
Investor relations Next earnings report Next confirmed report Nov 9, 2026 Consensus EPS estimate $-0.13 Past earnings dates Reported Fiscal period EPS estimate 2026-08-10 Jun 2026 -$0.03 2026-05-05 Mar 2026 -$0.17 2026-03-02 Dec 2025 $0.27 2025-11-10 Sep 2025 $0.12 2025-08-05 Jun 2025 $0.04 2025-05-12 Mar 2025 -$0.04 2025-03-03 Dec 2024 $0.38 2024-11-12 Sep 2024 $0.22
Filings and sources Company website surgerypartners.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports Similar companies HCA Healthcare, Inc. (HCA) · DaVita Inc. (DVA) · Universal Health Services Inc (UHS) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA) · Agilent Technologies, Inc. (A) · IQVIA Holdings Inc. (IQV)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades